Anaesthesia complication rates

Article

Anaesthesia administered by sharp needles carries a greater risk of serious complications than subtenons cannula administration, according to a study published online ahead of print in Eye.

Anaesthesia administered by sharp needles carries a greater risk of serious complications than subtenons cannula administration, according to a study published online ahead of print in Eye.

Rob L. Johnston of Gloucestershire Eye Department, Cheltenham General Hospital, UK and colleagues evaluated the Cataract National Dataset, which contains electronically recorded patient data gathered from 12 UK National Health Service Trusts.

An ophthalmologist administered anaesthetic in 56.7% of the 55 567 operations performed; anaesthetic was administered by an anaesthetist for 42.1% of operations, and by an assistant in 0.3% of the cases (personnel administering anaesthesia in the remaining 0.9% was unrecorded).

Across all Trusts, local anaesthesia was used in 95.5% of cases; topical anaesthesia, 22.3%; topical and intracameral, 4.7%; subtenons, 46.9%; peribulbar, 19.5%; retrobulbar, 0.5%. Minor complications (≥1) associated with sharp needle or subtenons cannula administration occurred in 4.3% of cases, with subtenons administration being 2.3 times more likely than sharp needles to cause minor complications. Serious complications associated with sharp needle or subtenons cannula administration occurred in 0.066% of cases (n=25), with sharp needle administration being 2.5 times more likely than subtenons to cause serious complications.

The team noted that, although subtenons administration of anaesthesia was associated with a greater risk of minor complications, sharp needles were more likely to produce serious complications.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.